Mukka Proteins Limited Amends Insider Trading Code Following Board Approval

2 min read     Updated on 13 Feb 2026, 10:07 AM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Mukka Proteins Limited has amended its insider trading code following Board approval on 12th February 2026, pursuant to SEBI regulations. The comprehensive code defines designated persons, UPSI categories, trading restrictions, pre-clearance requirements, and establishes a digital database maintenance system with strict compliance and penalty provisions.

32503068

*this image is generated using AI for illustrative purposes only.

Mukka Proteins Limited has amended its Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders following Board approval on 12th February 2026. The amendment was made pursuant to Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, based on the recommendation of the Audit Committee.

Key Provisions of the Amended Code

The updated code establishes comprehensive guidelines for insider trading regulations and defines various categories of persons subject to these provisions. The code identifies designated persons including promoters, promoter groups, all members of the Board of Directors, executive directors, key executives, and their immediate relatives.

Category Details
Designated Persons Promoters, Board members, Executive Directors, Key Executives
Coverage Immediate relatives and insiders with UPSI access
Compliance Officer Kalandan Mohammed Althaf, Whole-Time Director & CFO
Contact +918244252889, investors@mukkaproteins.com

Definition of Unpublished Price Sensitive Information

The code provides detailed definitions of unpublished price sensitive information (UPSI), which includes information not generally available that could materially affect security prices. Key categories of UPSI encompass:

  • Financial results and dividend declarations
  • Changes in capital structure and mergers or acquisitions
  • Key managerial personnel changes and rating modifications
  • Fund raising activities and management control agreements
  • Fraud, defaults, or arrests of key personnel
  • Regulatory actions and litigation outcomes

Trading Restrictions and Pre-clearance Requirements

The amended code establishes strict trading restrictions for designated persons when in possession of UPSI. All designated persons must obtain pre-clearance before executing any transactions in company securities. The code mandates a minimum holding period of six months for acquired securities and requires submission of transaction reports within two trading days.

Requirement Details
Pre-clearance Mandatory for all designated persons
Minimum Holding Six months from acquisition date
Reporting Timeline Within two trading days of transaction
Database Maintenance Eight years preservation period

Digital Database and Compliance Framework

The Compliance Officer must maintain a structured digital database with time stamping and audit trails containing details of UPSI and persons with whom information is shared. The database must be preserved for at least eight years after completion of relevant transactions. The code also establishes a "Chinese Wall" concept to prevent misuse of confidential information between inside and public areas.

Penalties and Enforcement

Violations of the code may result in disciplinary action, penalties, debarment, suspension, or criminal prosecution. The company must promptly inform stock exchanges of any violations observed by the Board of Directors. The code clarifies that company disciplinary actions do not preclude SEBI and other authorities from taking separate enforcement actions.

The amended code is available on the company's website at https://mukkaproteins.com/policy.php and has been communicated to both NSE and BSE for further dissemination to market participants.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-1.57%+7.00%+13.29%-8.57%-28.51%-40.66%

Mukka Proteins Board Approves Rs. 19.64 Lakh Acquisition to Make Haris Marine Products Wholly Owned Subsidiary

2 min read     Updated on 12 Feb 2026, 07:42 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Mukka Proteins Limited's board approved acquisition of 2,000 equity shares in subsidiary Haris Marine Products Private Limited for Rs. 19.64 lakh on February 12, 2026. The transaction will increase shareholding from 98% to 100%, making it a wholly owned subsidiary. The acquisition, expected to complete by June 30, 2026, supports the company's strategic expansion plans in fish meal and fish oil manufacturing.

32451178

*this image is generated using AI for illustrative purposes only.

Mukka proteins Limited's board of directors has approved a strategic acquisition that will consolidate its control over subsidiary Haris Marine Products Private Limited. The board meeting held on February 12, 2026, sanctioned the purchase of additional equity shares to achieve complete ownership of the subsidiary company.

Acquisition Details

The board approved the acquisition of 2,000 equity shares of face value Rs. 100 each in Haris Marine Products Private Limited for a total consideration of Rs. 19,64,000. This transaction will be executed through acquisition from existing shareholders on a cash basis.

Parameter: Details
Shares to be Acquired: 2,000 equity shares
Face Value per Share: Rs. 100
Total Consideration: Rs. 19,64,000
Payment Method: Cash
Expected Completion: June 30, 2026

Shareholding Structure Change

Upon completion of this acquisition, Mukka Proteins Limited's shareholding in Haris Marine Products Private Limited will increase from the current 98% to 100%, making it a wholly owned subsidiary.

Shareholding Status: Percentage
Present Shareholding: 98%
Post-acquisition Shareholding: 100%
Change in Shareholding: +2%

Target Company Profile

Haris Marine Products Private Limited operates in the same industry as its parent company, focusing on manufacturing and exporting fish meal and fish oil. The company was incorporated on October 30, 2019, and maintains its business presence in India.

Financial Parameter: Amount/Details
Authorized Capital: Rs. 1,00,00,000
Paid-up Capital: Rs. 1,00,00,000
Turnover (FY 2024-25): Nil
PAT (FY 2024-25): Rs. 2,24,01,700

Historical Performance

The subsidiary's revenue performance over the past three years shows:

  • March 2023: Rs. 50,95,31,673
  • March 2024: Nil
  • March 2025: Nil

Strategic Rationale

The proposed investment forms part of Mukka Proteins Limited's strategic investment plans to expand its core business operations. Since both companies operate in the fish meal and fish oil manufacturing and export sector, this acquisition aligns with the parent company's business objectives and will strengthen its market position.

The transaction is classified as a related party transaction under the Companies Act, 2013, given the existing subsidiary relationship. The company has confirmed that the investment will be executed on an arm's length basis, with promoters having interest in Haris Marine Products Private Limited through their existing shareholding and directorship positions.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-1.57%+7.00%+13.29%-8.57%-28.51%-40.66%

More News on Mukka Proteins

1 Year Returns:-28.51%